文献速递慢阻肺

GOLD 2017分类对COPD患者死亡率的预测:一项队列研究

Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study.
PubMed 文献 · Lancet Respir Med · 2018-01-10

该全国性队列研究纳入丹麦33 765例COPD门诊患者,比较GOLD 2007、2011和2017分类对全因和呼吸死亡率的预测能力。GOLD 2017的ABCD分组3年死亡率从A组到D组升高,但B组高于C组;仅用ABCD分组预测并不优于旧版,而细分为16个亚组时预测更准确。

要点

  • 仅用ABCD分组预测死亡率未优于2007/2011版,细分16亚组时预测更准确。

核心结论

  • GOLD 2017的ABCD分类对全因和呼吸死亡率的预测并不比2007和2011版更准确。

研究设计与样本

  • 全国性队列研究,纳入2008年1月1日至2013年11月30日丹麦医院COPD门诊患者33 765例,评估全因死亡率。
  • 纳入标准:年龄≥30岁,主要诊断COPD(ICD-10 J44.X)或急性呼吸衰竭(ICD-10 J96.X)合并COPD为次要诊断,且FEV1、BMI、mMRC评分和吸烟状态数据完整。

临床怎么用

  • 临床使用GOLD 2017评估COPD死亡风险时,不应仅依赖ABCD分组,可结合spirometric 1-4分期细分亚组以提升预测准确性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 classification separates the spirometric 1-4 staging from the ABCD groups defined by symptoms and exacerbations. Little is known about how this new classification predicts mortality in patients with chronic obstructive pulmonary disease (COPD). We aimed to establish the predictive ability of the GOLD 2017 classification, compared with earlier classifications, for all-cause and respiratory mortality, both when using its main ABCD groups and when further subdividing according to spirometric 1-4 staging. METHODS: In this nationwide cohort study, we enrolled patients with COPD with data available in the Danish registry for COPD. To be included in this registry, individuals must have been outpatients in hospital-based pulmonary clinics in Denmark. Eligible patients were aged 30 years or older; had received a primary diagnosis of COPD (International Classification of Diseases [ICD]-10 J44.X) or acute respiratory failure (ICD-10 J96.X) in combination with COPD (ICD-10 J44.X) as a secondary diagnosis; and had complete data on FEV1, body-mass index, modified Medical Research Council dyspnoea scale score, and smoking status. We categorised eligible patients with complete data according to the 2007, 2011, and 2017 GOLD classifications at the first contact with an outpatient clinic. For the GOLD 2017 classification, we further subdivided the patients by spirometry into 16 subgroups (1A to 4D). We calculated adjusted hazard ratios (HRs) for all-cause and respiratory mortality and compared the predictive ability of the three GOLD classifications (2007, 2011, and 2017) using receiver operating curves. FINDINGS: We enrolled 33 765 patients with COPD, who were outpatients in Danish hospitals between Jan 1, 2008, and Nov 30, 2013, in the main cohort assessed for all-cause mortality. 22 621 of these patients had data available on cause-specific mortality (respiratory) and were included in a subcohort followed from Jan 1, 2008, to Dec 31, 2011. For the GOLD 2017 classification, 3 year mortality increased with increasing exacerbations and dyspnoea from group A (all-cause mortality 10·0%, respiratory mortality 3·0%) to group D (all-cause mortality 36·9%, respiratory mortality 18·0%). However, 3 year mortality was higher for group B patients (all-cause mortality 23·8%, respiratory mortality 9·7%) than for group C patients (all-cause mortality 17·4%, respiratory mortality 6·4%). Compared with group A, adjusted HRs for all-cause mortality ranged from 2·05 (95% CI 1·87-2·26) for group B, to 1·47 (1·31-1·65) for group C, and to 3·01 (2·75-3·30) for group D. Area under the curve for all-cause mortality was 0·61 (95% CI 0·60-0·61) for GOLD 2007, 0·61 (0·60-0·62) for GOLD 2011, and 0·63 (0·53-0·73) for GOLD 2017. Area under the curve for respiratory mortality was 0·64 (0·62-0·65) for GOLD 2007, 0·63 (0·62-0·64) for GOLD 2011, and 0·65 (0·53-0·78) for GOLD 2017. The GOLD 2017 classification based on ABCD groups only did not predict mortality better than the earlier 2007 and 2011 GOLD classifications. However, when 16 subgroups (1A to 4D) were defined, the new classification predicted mortality more accurately than the previous systems (p<0·0001). INTERPRETATION: We showed that the new GOLD 2017 ABCD classification does not predict all-cause and respiratory mortality more accurately than the previous GOLD systems from 2007 and 2011. FUNDING: Danish Lung Association, Program for Clinical Research Infrastructure.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Gedebjerg A, Szépligeti SK, Wackerhausen LH, et al. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study. Lancet Respir Med. 2018. PMID: 29331311. doi:10.1016/S2213-2600(18)30002-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。